Evidence map›Paper›PMID 30459736›Full record

ArticleFrontiers in microbiology2018

Hydroxytyrosol (HT) Analogs Act as Potent Antifungals by Direct Disruption of the Fungal Cell Membrane.

George Diallinas, Nausica Rafailidou, Ioanna Kalpaktsi, Aikaterini Christina Komianou, Vivian Tsouvali, Iliana Zantza, Emmanuel Mikros, Alexios Leandros Skaltsounis, Ioannis K Kostakis

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

  1. A comprehensive review ofRSC advances · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Almond [Molecules (Basel, Switzerland) · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. NaturalFoods (Basel, Switzerland) · 2021
    Article
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

George DiallinasDepartment of Biology, National and Kapodistrian University of Athens, Athens, Greece.
Nausica RafailidouDepartment of Biology, National and Kapodistrian University of Athens, Athens, Greece.
Ioanna KalpaktsiDepartment of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.
Aikaterini Christina KomianouDepartment of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.
Vivian TsouvaliDepartment of Biology, National and Kapodistrian University of Athens, Athens, Greece.
Iliana ZantzaDepartment of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.
Emmanuel MikrosDepartment of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.
Alexios Leandros SkaltsounisDepartment of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.
Ioannis K KostakisDepartment of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.
National and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fungal infections constitute an emerging threat and a prevalent health problem due to increasing number of immunocompromised people and pharmacological or other treatments aiming at viral infections, cancer or allergies. Currently used antifungals suffer from inefficiency, toxic side effects and developing drug-resistance. Additionally, over the last two decades no new classes of antifungals have been approved, emphasizing the urgent need for developing a novel generation of antifungals. Here, we investigate the antifungal activity of a series of chemically synthesized Hydroxytyrosol (HT) analogs. HT is one of the major phenolic compounds in olive oil, shown to possess radical-scavenging antioxidant, antiproliferative, proapoptotic and anti-inflammatory activities. No previous report has studied HT analogs as antifungals. We show that specific analogs have broad and strong antifungal activity, significantly stronger than the parent compound HT. Using

Indexed as

antimicrobialAspergillus nidulansfungal pathogensplasma membraneresistance

Identifiers

PMID30459736
PMCPMC6232300
OpenAlexW2949692447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.